233 related articles for article (PubMed ID: 32585221)
1. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
[TBL] [Abstract][Full Text] [Related]
2. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
[TBL] [Abstract][Full Text] [Related]
3. Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
Cusimano MC; Moineddin R; Chiu M; Ferguson SE; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2021 Jun; 224(6):585.e1-585.e30. PubMed ID: 33359174
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
5. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
[TBL] [Abstract][Full Text] [Related]
6. The risk of stroke after bilateral salpingo-oophorectomy at hysterectomy for benign diseases: A nationwide cohort study.
Lai JC; Chou YJ; Huang N; Chen HH; Wang KL; Wang CW; Shen IH; Chang HC
Maturitas; 2018 Aug; 114():27-33. PubMed ID: 29907243
[TBL] [Abstract][Full Text] [Related]
7. Concomitant Bilateral Salpingo-Oophorectomy at Hysterectomy: Differences by Race and Menopausal Status in the Veterans Affairs Health Care System, 2007-2014.
Bossick AS; Katon JG; Gray KE; Ma EW; Callegari LS
J Womens Health (Larchmt); 2020 Dec; 29(12):1513-1519. PubMed ID: 33095114
[No Abstract] [Full Text] [Related]
8. Long-term outcomes of hysterectomy with bilateral salpingo-oophorectomy: a systematic review and meta-analysis.
Hassan H; Allen I; Sofianopoulou E; Walburga Y; Turnbull C; Eccles DM; Tischkowitz M; Pharoah P; Antoniou AC
Am J Obstet Gynecol; 2024 Jan; 230(1):44-57. PubMed ID: 37364803
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy.
Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA
Obstet Gynecol; 2014 Jan; 123(1):65-72. PubMed ID: 24463665
[TBL] [Abstract][Full Text] [Related]
10. Changing trends in Black-White racial differences in surgical menopause: a population-based study.
Wright MA; Doll KM; Myers E; Carpenter WR; Gartner DR; Robinson WR
Am J Obstet Gynecol; 2021 Nov; 225(5):502.e1-502.e13. PubMed ID: 34111405
[TBL] [Abstract][Full Text] [Related]
11. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
Smith MJ; Gerber D; Olsen A; Khouri OR; Wang Y; Liu M; Smith J; Pothuri B
Am J Obstet Gynecol; 2021 Nov; 225(5):508.e1-508.e10. PubMed ID: 34171390
[TBL] [Abstract][Full Text] [Related]
12. In-hospital complications of bilateral salpingo-oophorectomy at benign hysterectomy: a population-based cohort study.
Lai JC; Chen HH; Chu KH; Wang KL; Huang N; Hu HY; Chou YJ
Menopause; 2017 Feb; 24(2):187-195. PubMed ID: 27779566
[TBL] [Abstract][Full Text] [Related]
13. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term outcomes for single-port risk-reducing salpingo-oophorectomy with and without hysterectomy for women at risk for gynecologic cancer.
Carr CE; Chambers L; Jernigan AM; Freeman L; Escobar PF; Michener CM
Int J Gynecol Cancer; 2021 Feb; 31(2):215-221. PubMed ID: 32948638
[TBL] [Abstract][Full Text] [Related]
15. Intention matters: Success rate of bilateral salpingo-oophorectomy at the time of vaginal hysterectomy for pelvic organ prolapse.
Messingschlager C; Ferrando CA; Chang OH
Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():54-58. PubMed ID: 36773471
[TBL] [Abstract][Full Text] [Related]
16. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.
Cusimano MC; Chiu M; Ferguson SE; Moineddin R; Aktar S; Liu N; Baxter NN
BMJ; 2021 Dec; 375():e067528. PubMed ID: 34880044
[TBL] [Abstract][Full Text] [Related]
17. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
[TBL] [Abstract][Full Text] [Related]
18. A Revised Markov Model Evaluating Oophorectomy at the Time of Hysterectomy for Benign Indication: Age 65 Years Revisited.
Rush SK; Ma X; Newton MA; Rose SL
Obstet Gynecol; 2022 May; 139(5):735-744. PubMed ID: 35576331
[TBL] [Abstract][Full Text] [Related]
19. Premenopausal gynecologic surgery and survival among black and white women with breast cancer.
Roberson ML; Nichols HB; Olshan AF; A Troester M; Robinson WR
Cancer Causes Control; 2020 Feb; 31(2):105-112. PubMed ID: 31828465
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
